ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,200Medicare Part D Prescriptions Filled, Including Refills

Rank: 73 out of 2094

$1.1M Total Retail Price of All Prescriptions

Rank: 69 out of 2094

501 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
57% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 501 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

10% of this provider’s 501 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

1% of this provider’s 11,409 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

32% of this provider’s prescriptions were for brand-name drugs, compared to an average of 32%.

Prescription Price

$78 was the average price of a prescription from this provider, compared to $78 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
LEVOTHYROXINE SODIUM 524 430 1 3
OMEPRAZOLE 407 292 2 4
FUROSEMIDE 364 320 3 6
AMLODIPINE BESYLATE 299 273 4 2
SIMVASTATIN 240 195 5 1
ATORVASTATIN CALCIUM 236 202 6 5
WARFARIN SODIUM 227 227 7 11
SERTRALINE HCL 210 194 8 26
DONEPEZIL HCL 202 170 9 20
HYDROCODONE-ACETAMINOPHEN 178 133 S3 10 42
METOPROLOL SUCCINATE 169 153 11 9
LISINOPRIL 164 159 12 7
ZOLPIDEM TARTRATE 159 127 13 14
METFORMIN HCL 157 131 14 8
DIOVAN 148 140 15 13
CYMBALTA 141 111 16 61
GABAPENTIN 140 91 17 23
OXYBUTYNIN CHLORIDE ER 135 95 18 138
ATENOLOL 129 116 19 21
POTASSIUM CHLORIDE 123 97 20 24
TRAMADOL HCL 122 92 21 33
CARBIDOPA-LEVODOPA 118 118 22 102
NAMENDA 114 102 23 32
NEXIUM 114 98 23 16
GLIMEPIRIDE 110 102 25 31
PRAVASTATIN SODIUM 110 85 25 18
PREDNISONE 109 98 27 54
CRESTOR 109 96 27 15
LYRICA 109 76 27 85
LOSARTAN POTASSIUM 107 104 30 17
ESCITALOPRAM OXALATE 104 81 31 46
ADVAIR DISKUS 103 80 32 36
DIOVAN HCT 101 79 33 28
LANTUS 100 76 34 66
DIVALPROEX SODIUM 99 75 35 69
TAMSULOSIN HCL 93 71 36 29
PAROXETINE HCL 92 78 37 77
CLOPIDOGREL 92 75 37 22
FAMOTIDINE 85 79 39 34
AZITHROMYCIN 84 76 40 27
METOPROLOL TARTRATE 83 77 41 10
LEVOFLOXACIN 83 65 41 70
TRIAMTERENE-HCTZ 80 56 43 87
LISINOPRIL-HYDROCHLOROTHIAZIDE 78 63 44 55
CARVEDILOL 78 63 44 19
IPRATROPIUM-ALBUTEROL 75 69 46 92
PANTOPRAZOLE SODIUM 73 64 47 37
FLUTICASONE PROPIONATE 73 46 47 41
MELOXICAM 71 67 49 49
OXYCODONE HCL 71 23 S2 49 63
SPIRIVA 71 60 49 60
FENOFIBRATE 70 39 52 104
PLAVIX 70 55 52 38
NIASPAN 69 38 54 145
DIGOXIN 63 63 55 51
LOSARTAN-HYDROCHLOROTHIAZIDE 62 48 56 52
NOVOLOG FLEXPEN 61 41 57 142
RISPERIDONE 61 47 57 56
RANITIDINE HCL 61 40 57 80
BYSTOLIC 60 57 60 83
TRAZODONE HCL 60 58 60 72
ALLOPURINOL 60 51 60 50
SULFAMETHOXAZOLE-TRIMETHOPRIM 60 55 60 182
PROAIR HFA 60 49 60 45
HYDROCHLOROTHIAZIDE 59 54 65 12
CLONIDINE HCL 59 54 65 62
FENTANYL 56 50 S2 67 68
OXYCODONE-ACETAMINOPHEN 56 47 S2 67 40
DILTIAZEM 24HR CD 56 51 67 110
VERAPAMIL ER 55 53 70 161
GLIPIZIDE 54 38 71 82
CARBAMAZEPINE 54 13 71 206
ZETIA 53 31 73 79
AMLODIPINE-ATORVASTATIN 53 47 73 513
AMLODIPINE BESYLATE-BENAZEPRIL 52 39 75 58
ALENDRONATE SODIUM 52 44 75 30
NITROFURANTOIN MONO-MACRO 52 48 75 265
MORPHINE SULFATE ER 51 50 S2 78 192
CEFDINIR 51 41 78 309
SINGULAIR 50 19 80 64
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 20, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.